Aligos Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
/ 
Frequently asked questions
To buy Aligos Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Aligos Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Aligos Therapeutics Inc. is ALGS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Aligos Therapeutics Inc. has its primary listing on NASDAQ. You can trade Aligos Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Aligos Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Aligos Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Aligos Therapeutics Inc..